Associated Papers
Effects of pathological mutations on the CHCHD2 monomer structure: A study by AlphaFold3 linked to the generation of conformational ensembles.
Özmen ZA et al.
Computers in Biology and Medicine, 2025
Role of the mitochondrial regulatory factor CHCHD2 in neurodegenerative diseases.
Guo X et al.
Frontiers in Neuroscience, 2025
Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
Ren YL et al.
Molecular Neurobiology, 2024
Pathogenesis of Parkinson's disease: from hints from monogenic familial PD to biomarkers.
Hattori N et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2024
Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
Torii S et al.
Embo Molecular Medicine, 2023
Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?
Ikeda A et al.
Frontiers in Cell and Developmental Biology, 2022
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
Kee TR et al.
Frontiers in Aging Neuroscience, 2021
Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
Zhou W et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry, 2020
Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A et al.
Human Molecular Genetics, 2019
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Imai Y et al.
International Journal of Molecular Sciences, 2019
A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.
Ikeda A et al.
Parkinsonism & Related Disorders, 2017
Select a paper to view details